4.7 Article

Preconditioning-Activated AKT Controls Neuronal Tolerance to Ischemia through the MDM2-p53 Pathway

Journal

Publisher

MDPI
DOI: 10.3390/ijms22147275

Keywords

AKT; MDM2; p53; PI3K; ischemic tolerance; preconditioning

Funding

  1. Instituto de Salud Carlos III [PI18/00103, PI18/00285, RD16/0019/0018, CB16/10/00282]
  2. MICINN [PID2019-105699RBI00/AEI/10.13039/501100011033, RED2018-102576-T, SAF2017-90794-REDT]
  3. Junta de Castilla y Leon (Escalera de Excelencia) [CLU-2017-03, CSI151P20]
  4. Ayudas Equipos Investigacion Biomedicina 2017 Fundacion BBVA
  5. Fundacion Ramon Areces
  6. European Regional Development Fund
  7. European Union [686009]

Ask authors/readers for more resources

The study identified that ischemic preconditioning induces activation of the PI3K/AKT signaling pathway, promoting neuronal tolerance by controlling the MDM2-p53 interaction. These findings offer a novel mechanistic pathway for IPC-induced neuroprotection, suggesting that AKT could be a potential therapeutic target against ischemic injury.
One of the most important mechanisms of preconditioning-mediated neuroprotection is the attenuation of cell apoptosis, inducing brain tolerance after a subsequent injurious ischemia. In this context, the antiapoptotic PI3K/AKT signaling pathway plays a key role by regulating cell differentiation and survival. Active AKT is known to increase the expression of murine double minute-2 (MDM2), an E3-ubiquitin ligase that destabilizes p53 to promote the survival of cancer cells. In neurons, we recently showed that the MDM2-p53 interaction is potentiated by pharmacological preconditioning, based on subtoxic stimulation of NMDA glutamate receptor, which prevents ischemia-induced neuronal apoptosis. However, whether this mechanism contributes to the neuronal tolerance during ischemic preconditioning (IPC) is unknown. Here, we show that IPC induced PI3K-mediated phosphorylation of AKT at Ser(473), which in turn phosphorylated MDM2 at Ser(166). This phosphorylation triggered the nuclear stabilization of MDM2, leading to p53 destabilization, thus preventing neuronal apoptosis upon an ischemic insult. Inhibition of the PI3K/AKT pathway with wortmannin or by AKT silencing induced the accumulation of cytosolic MDM2, abrogating IPC-induced neuroprotection. Thus, IPC enhances the activation of PI3K/AKT signaling pathway and promotes neuronal tolerance by controlling the MDM2-p53 interaction. Our findings provide a new mechanistic pathway involved in IPC-induced neuroprotection via modulation of AKT signaling, suggesting that AKT is a potential therapeutic target against ischemic injury.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available